Application of enamel matrix derivate, deproteinized bovine bone and collagen membrane for the reconstructive treatment of periimplant intrabony defect: a randomized clinical trial

ThinkingPerio Research0 个研究点目标入组 40 人开始时间: 2021年4月15日最近更新: 2023年10月16日

适应症

试验速览

暂无简介。

•1. Patients that show radiographically peri-implant intraosseous defects of at least 3 mm depth
•2. Depth of clinical probing =5 mm with bleeding and/or suppuration
•3. Intra-surgically, the infra-osseous defect must have at least one intraosseous component of 3 mm and a width of no more than 4 mm
•4. The implant to be treated must have been in function for at least 12 months

•1. Patients with diabetes mellitus, hyperparathyroidism and/or osteomalacia
•2. Patients treated with corticosteroids
•3. Patients medicated with drugs that induce gingival hyperplasia
•4. Allergic to penicillin or who have taken antibiotics in the last 6 months
•5. Pregnant or breastfeeding patients
•6. Patients with osteoporosis
•7. Impossibility of stabilizing bovine bone with collagen or primary closure of soft tissue
•8. Patients with collagen allergy
•9. Patients treated with radiotherapy

发起方

ThinkingPerio Research